<DOC>
	<DOCNO>NCT00888784</DOCNO>
	<brief_summary>The investigator conduct randomize , control trial ( RCT ) study efficacy beta blocker versus endoscopic cyanoacrylate injection prevention gastric variceal ( GOV2 IGV1 ) rebleeding improvement survival .</brief_summary>
	<brief_title>Secondary Prophylaxis Gastric Variceal Bleed</brief_title>
	<detailed_description />
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Patients GOV2 without esophageal varix IGV1 , bleed GV include Presence esophageal varix GOV2 GOV1 ; contraindication betablocker therapy cyanoacrylate injection Prior injection cyanoacrylate sclerotherapy GV GV ligation , transjugular intrahepatic portosystemic shunt , balloonoccluded retrograde transvenous obliteration , balloonoccluded endoscopic injection sclerotherapy GV , shunt operation prevention rebleeding GV Patients already betablocker nitrate Undetermined origin bleed esophageal varix gastric varix Hepatic encephalopathy grade III/IV Hepatorenal syndrome Hepatocellular carcinoma Presence deep jaundice ( serum bilirubin &gt; 10 mg/dl ) Uremia Cerebrovascular accident Cardiorespiratory failure Pregnancy patient give informed consent endoscopic procedure</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>